January 1, 2008The Journal of Law Medicine & Ethics
Fixed-Dose Isosorbide Dinitrate-Hydralazine: Race-Based Cardiovascular Medicine Benefit or Mirage?
Why the study?
Does fixed-dose isosorbide dinitrate and hydralazine improve outcomes in African Americans with heart failure?
Population
African Americans with heart failure
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports targeted use of isosorbide dinitrate/hydralazine in African American HF; leaves open ethical questions on race-based prescribing.
Structured PICO
Does fixed-dose isosorbide dinitrate and hydralazine improve outcomes in African Americans with heart failure?
P
Population
African Americans with heart failure
I
Intervention
Fixed-dose combination of isosorbide dinitrate and hydralazine (ISDN/Hyd)
This review underscores the clinical importance of utilizing fixed-dose isosorbide dinitrate and hydralazine in African American patients with heart failure, supporting evidence-based targeted therapies.
Cite This Study
Keith C. Ferdinand (2008) studied this question.